Aspen Neuroscience, which is developing stem cell therapies for Parkinson's disease, sold 9.37 million shares, slightly below ...

While praising the breadth of its pipeline, AstraZeneca has launched a three-year cost-cutting programme that will aim to ...

Belén Garijo, who took over the reins of the French pharma group in April, said this morning that Sanofi's "whole ...

Among the highlights of UK Chancellor John Healey's first Budget was more than £1 billion in investment by Convatec, Vertex ...

The US federal government has awarded $99 million in funding for a one-shot vaccine against the Bundibugyo virus (BDBV), the ...

Novartis has a much-anticipated approval for its spinal muscular atrophy (SMA) treatment onasemnogene abeparvovec in the US, getting a green light for a new version that can make more patients ...

Dren Bio has closed a sizeable private financing round, raising $350 million to fund pivotal trials of its potentially ...

Flagship Pioneering has formed a new AI-focused biotech company, called Etcelera, by combining the platforms of three firms ...

Eli Lilly has added another arrow to the quiver of its new diabetes and weight-loss therapy retatrutide, comprehensively ...

While Lilly's injectable incretin products are romping away, the performance of its oral GLP-1 agonist Foundayo (orforglipron) – currently competing head-to-head with Novo's first-to-market Wegovy ...

While Anthropic has not disclosed the number of shares to be released, their price range, or a date for the listing, ...

Switzerland's Ferring Pharma has reached an agreement to buy US women's health startup Gameto for up to $1.38 billion, ...